Consortia / Investigational Agents / DCTD / Pharmaceutical Collaborators / Appendices Appendix I NCI-Cooperative Group / Cooperative Groups / /
Country
United States / / /
Event
FDA Phase / Business Partnership / /
Facility
National Cancer Institute / Charles Hall / /
IndustryTerm
Cancer Therapy / clinical trials network / Cancer Treatment / clinical trial site / agent development contractors / /
MedicalCondition
aggressive neoplasms / tumor / Cancer / /
Organization
National Cancer Institute / Food and Drug Administration / CTEP Protocol Review Committee / National Study Commission on Cytotoxic Exposure / Introduction Investigator Handbook Committee / Protocol and Information Office / Treatment Referral Center / Protocol Administration / Coordinating Center / Administration of Study Agents / FDA / Department of Health and Human Services / Clinical Trials Monitoring Service / NCI Board of Scientific / /
Person
S. Gary Smith / M.S. Joan Mauer Margaret Mooney / Jan M. Casadei / Martha Kruhm / Austin Doyle / B.A. Larry Rubenstein / Jian Zhang / D. Shanda Finnigan / Sherry Ansher / Jeannette Wick / G.A. Naoko Takebe / Grant Awardees / Patricia R. Schettino / Jeffrey Abrams / /
Position
Investigator / Chair a Protocol/Group / Editor / Principal Investigator / Advisors / Affiliate Investigator / proprietor / NCI Investigator / Investigator and Protocol/Group Chair / Governor / individual clinical investigator / Associate Director / Chair The Protocol/Group / Chair / Private / Chief / Regulatory Affairs / Director / Cancer Therapy Evaluation Program / R.N. / /
Product
Single Agent / CTEP / clinical / accountability / /
A Handbook for Clinical Investigators Conducting Therapeutic Clinical Trials Supported by CTEP, DCTD, NCI